Our study, together with the following papers showed that despite their predictive role as tumor suppressors, the ERK-inhibitory MKPs/DUSPs can be linked to tumor progression, in other words, ERK-active cancer cells are addicted to DUSPs for growth. The gene discussed is MAPK1; the disease is neoplasm.